The Steering Committee

The day-to-day management, as well as the representation of the EBF as far as the day-to-day management and external representation is concerned is delegated from the Board of Directors to a Steering Committee (SC) elected amongst the Pharma members. SC composition reviewed and/or confirmed at strategy meeting of uneven year. The SC currently consists of the following 5 people :

• Philip Timmerman, Belgium, Chairman of the EBF
• Steve White, GlaxoSmithKline, United Kingdom
• Magnus Knutsson, Ferring Pharmaceuticals, Denmark
• Joanne Goodman, AstraZeneca, United Kingdom